About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press release and other company information, visit Watson Pharmaceuticals' website at http://www.watson.com.
Statements contained in this press release that refer to Watson's
estimated or anticipated future results or other non-historical facts are
forward-looking statements that reflect Watson's current perspective of
existing trends and information as of the date of this release. For
instance, any statements in this press release concerning prospects related
to Watson's strategic initiatives, product introductions and anticipated
financial performance are forward-looking statements. It is important to
note that Watson's goals and expectations are not predictions of actual
performance. Watson's performance, at times, will differ from its goals and
expectations. Actual results may differ materially from Watson's current
expectations depending upon a number of factors affecting Watson's
business. These factors include, among others, the inherent uncertainty
associated with financial projections; the impact of competitive products
and pricing; successful integration of strategic transactions; the ability
to recognize the anticipated synergies and benefits of strategic
transactions; variability of revenue mix between the Company's Brand,
Generic and Distribution business units; periodic dependence on a small
|SOURCE Watson Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved